Many studies have demonstrated elevated circulating levels of HMGB1 and decreased circulating levels of sRAGE in patients with autoimmune diseases such as rheumatoid arthritis (RA) [6,7], systemic lupus erythematosus (SLE) [8–10] and adult onset Still’s disease [11]. This evidence concerns the gene HMGB1 and systemic lupus erythematosus.